90 related articles for article (PubMed ID: 21987494)
1. Fine-needle aspiration cytology of triple-negative basal-like breast cancer.
Akashi S; Kuwabara H; Kurisu Y; Takahashi Y; Yasuda E; Takeshita A; Ishizaki S; Tsuji M; Shibayama Y
Diagn Cytopathol; 2013 Apr; 41(4):283-7. PubMed ID: 21987494
[TBL] [Abstract][Full Text] [Related]
2. Cytologic features of triple-negative breast carcinoma.
Bonzanini M; Morelli L; Bonandini EM; Leonardi E; Pertile R; Dalla Palma P
Cancer Cytopathol; 2012 Dec; 120(6):401-9. PubMed ID: 22833438
[TBL] [Abstract][Full Text] [Related]
3. P-cadherin and vimentin are useful basal markers in breast cancers.
Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features.
El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR
Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
8. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
[TBL] [Abstract][Full Text] [Related]
9. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
[TBL] [Abstract][Full Text] [Related]
10. Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples.
Arihiro K; Oda M; Ogawa K; Tominaga K; Kaneko Y; Shimizu T; Matsumoto S; Oda M; Kurita Y; Taira Y
Jpn J Clin Oncol; 2013 Jan; 43(1):55-62. PubMed ID: 23225912
[TBL] [Abstract][Full Text] [Related]
11. Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried Diff-Quik smears.
Khan MZ; Haleem A; Al Hassani H; Kfoury H
Diagn Cytopathol; 2003 Oct; 29(4):185-93. PubMed ID: 14506669
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration cytology of insular carcinoma of thyroid.
Barwad A; Dey P; Nahar Saikia U; Gupta N; Rajwanshi A; Nijhawan R; Srinivasan R
Diagn Cytopathol; 2012 May; 40 Suppl 1():E43-7. PubMed ID: 21309014
[TBL] [Abstract][Full Text] [Related]
13. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
Nassar A; Sussman ZM; Lawson D; Cohen C
Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration biopsy of breast adenomyoepithelioma: a potential false positive pitfall and presence of intranuclear cytoplasmic inclusions.
Saad RS; Richmond L; Nofech-Mozes S; Ghorab Z
Diagn Cytopathol; 2012 Nov; 40(11):1005-9. PubMed ID: 21548117
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration cytology of apocrine adenosis of the breast: report on three cases.
Watanabe K; Nomura M; Hashimoto Y; Hanzawa M; Hoshi T
Diagn Cytopathol; 2007 May; 35(5):296-9. PubMed ID: 17427223
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.
Cakir A; Gonul II; Uluoglu O
Diagn Pathol; 2012 Oct; 7():145. PubMed ID: 23082819
[TBL] [Abstract][Full Text] [Related]
20. The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer.
Shibuta K; Ueo H; Furusawa H; Komaki K; Rai Y; Sagara Y; Kamada Y; Tamaki N
Breast Cancer; 2011 Oct; 18(4):292-8. PubMed ID: 20571962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]